Structure |
Chemical Name |
CAS |
MF |
|
2-Amino-5-nitrothiazole |
121-66-4 |
C3H3N3O2S |
|
HFPO OLIGOMER ACID FLUORIDES |
65208-35-7 |
C6F12O2 |
|
ethyl brevifolincarboxylate |
107646-82-2 |
C15H12O8 |
|
5.7-Dioxa-6-thia-spiro[2.5]octane-6-oxide |
89729-09-9 |
C5H8O3S |
|
2-Propenoic acid, 3-[1-[5-O-[bis(4-methoxyphenyl)phenylmethyl]-2-deoxy-β-D-erythro-pentofuranosyl]-1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl]-, (2E)- |
923023-62-5 |
C33H32N2O9 |
|
8-Benzyloxy-2'-deoxy-D-guanosine |
96964-90-8 |
C17H19N5O5 |
|
(S)-3-Cyano-5-methylhexanoic acid ethyl ester |
181289-39-4 |
C10H17NO2 |
|
Chloropretadalafil |
171489-59-1 |
C22H19ClN2O5 |
|
Trityl candesartan cilexetil |
170791-09-0 |
C52H48N6O6 |
|
Pneumocandin B0 |
135575-42-7 |
C50H80N8O17 |
|
7H-Pyrrolo[2,3-d]pyrimidine, 2-methyl- (7CI) |
89792-07-4 |
C7H7N3 |
|
3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione |
827026-45-9 |
C13H11N3O5 |
|
3-Acetylbiphenyl |
3112-01-4 |
C14H12O |
|
4-MAR |
|
|
|
1-CYCLOPROPYLMETHYL-PIPERAZINE DIHYDROCHLORIDE |
373608-42-5 |
C8H18Cl2N2 |
|
Δ3-Ceftiofur |
|
|
|
tert-butyl (3R)-3-(2-((2S,5R)-6-(benzyloxy)-7-oxo- 1,6-diazabicyclo[3.2.1]octane-2-carbonyl)hydrazine-1-carbonyl)pyrrolidine-1-carboxylate |
1463527-14-1 |
C24H33N5O6 |
|
Ethanaminium, N -[7-(ethylamino)-8-methyl-3 H -phenoxazin-3-ylidene]-2-[2-(2-methoxyethoxy)ethoxy]- N -[2-[2-(2-methoxyethoxy)
ethoxy]ethyl]- (ACI) |
2664217-62-1 |
C29H44N3O7+ |
|
7 8-DIHYDROXY-4-PHENYLCOUMARIN |
842-01-3 |
C15H10O4 |
|
1,4-dihydroxy-2naphthoic acid methyl ester |
77060-74-3 |
C12H10O4 |
|
2,4,8,10-Tetraoxa-3,9-dithiaspiro[5.5]undecane, 3,3,9,9-tetraoxide |
201419-80-9 |
C5H8O8S2 |
|
(SP-4-1)-[1,3-Bis[2,6-bis(1-propylbutyl)phenyl]-4,5-dichloro-1,3-dihydro-2H-imidazol-2-ylidene]dichloro(3-chloropyridine-κN)-Palladium |
1814936-54-3 |
C48H70Cl5N3Pd |
|
5-Mercapto-1H-tetrazole-1-methane sulphonic acid |
67146-22-9 |
C2H4N4O3S2 |
|
2,4-DICHLOROQUINOLINE |
703-61-7 |
C9H5Cl2N |
|
2,1-BENZISOXAZOLE |
271-58-9 |
C7H5NO |
|
3H-3-Azadibenzo[g,ij]naphth[2,1,8-cde]azulene |
2408302-78-1 |
C22H13N |
|
tert-butyl (R)-1-amino-1,3-dihydrospiro[indene-2,4'-piperidine]-1'-carboxylate |
|
|
|
(Trans)-tert-butyl 4-oxohexahydro-2H-pyrano[3,2-c]pyridine-6(7H)-carboxylate |
2177266-88-3 |
C13H21NO4 |
|
(3S,4S,5S)-Oseltamivir |
|
|
|
Pyrido[2,3-d]pyrimidin-4(3H)-one, 2-chloro- |
93049-38-8 |
C7H4ClN3O |
|
Edoxaban Impurity 19 (1S,2R,4S) Mesylate |
1807315-98-5 |
C17H26ClN5O6S |
|
9,9'-Spirobi[9H-fluoren]-2-amine, N-[1,1'-biphenyl]-2-yl-2',7'-bis(1,1-dimethylethyl)-N-(9,9-dimethyl-9H-fluoren-2-yl)- |
1365840-52-3 |
C60H53N |
|
4,5-diiodo-1-methyl-triazole |
1248676-71-2 |
C3H3I2N3 |
|
3-Bromonaphtho[2, 1-B]Benzofuran |
1678556-12-1 |
C16H9BrO |
|
(9H-fluoren-9-yl)methyl (R)-(4-cyclohexyl-1-(methylamino)-1-oxobutan-2-yl)carbamate |
|
|
|
4H-Pyrrolo[3,2-d]pyrimidin-4-one, 2-chloro-3,5-dihydro-3-methyl- |
2351929-82-1 |
C7H6ClN3O |
|
1-Pyrrolidinecarboxylic acid, 3-(4-bromo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester, (3R)- |
2198312-46-6 |
C12H18BrN3O2 |
|
2-[3-(1,1-dimethyl ethyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxyborane-2-yl) phenyl]-4-phenyl-pyridine |
2411987-38-5 |
C27H32BNO2 |
|
1-BOC-3-(METHOXY)AZETIDINE |
429669-07-8 |
C9H17NO3 |
|
3-(3'-TRIFLUOROMETHYL PHENYL) PROPANOL |
78573-45-2 |
C10H11F3O |
|
((2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methanol hydrochloride |
2416218-32-9 |
C8H14FNO.ClH |
|
disodium 4,5-dihydro-5-oxo-4-(phenylazo)-1-(4-sulphonatophenyl)-1H-pyrazole-3-carboxylate |
1934-22-1 |
C16H10N4Na2O6S |
|
3-acetyl-4-hydroxy-2-benzopyrone |
2555-37-5 |
C11H8O4 |
|
1,3,2-Dioxaborolane, 2-(12,12-dimethyl-12H-indeno[1,2-b]phenanthren-2-yl)-4,4,5,5-tetramethyl- |
1591629-74-1 |
C29H29BO2 |
|
Benzenamine, 4,4',4''-(2,4,6-pyrimidinetriyl)tris- (9CI) |
136009-19-3 |
C22H19N5 |
|
5-Pyrimidinecarboxylic acid, 2-[[4-[[2-(dimethylamino)ethyl]methylamino]-2-methoxy-5-nitrophenyl]amino]-4-(1-methyl-1H-indol-3-yl)-, 1-methylethyl ester |
1847464-89-4 |
C29H35N7O5 |
|
Cyclopenta[d]-1,2,3-oxathiazole-3(3aH)-carboxylic acid, tetrahydro-, 1,1-dimethylethyl ester, 2,2-dioxide, (3aS,6aR)- |
2145122-45-6 |
C10H17NO5S |
|
Methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate |
139481-44-0 |
C25H21N3O3 |
|
6-(Bromomethyl)-2,4-pteridinediamine hydrobromide |
52853-40-4 |
C7H8Br2N6 |
|
N-(4-CYANO-PHENYL)-GLYCINE |
42288-26-6 |
C9H8N2O2 |
|
DeoxyBenzoinOxime |
952-06-7 |
C14H13NO |
|
(2S,5R)-6-(tert-butyldimethylsilyloxy)-3-methyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-3-ene-2-carboxamide |
2209874-02-0 |
C14H25N3O3Si |
|
20-hydroxy Prostaglandin F2a |
|
|
|
1,6-Diazabicyclo[3.2.1]oct-3-ene-2-carboxamide, 6-hydroxy-3-methyl-7-oxo-, (1R,2S,5R)- |
2209874-17-7 |
C8H11N3O3 |
|
(6R,7R)-7-AMINO-8-OXO-3-((2S)-TETRAHYDROFURAN-2-YL)-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID 4-NITROBENZYL ESTER HCL |
655233-39-9 |
C18H20ClN3O6S |
|
Cefmetazole Impurity 4 |
68576-47-6 |
C15H17N7O4S4 |
|
Otilonium Bromide intermediates |
51444-79-2 |
C22H27NO4 |
|
2,5-Piperazinedione, 1-acetyl-3-(phenylmethylene)-, (3Z)- |
30166-30-4 |
C13H12N2O3 |
|
(5R)-1-[(5S)-5-(4-Fluorophenyl)-5-hydroxy-1-oxopentyl]-5-phenyl-2-pyrrolidinone |
1027552-46-0 |
C21H22FNO3 |
|
4F-MPH |
1354631-33-6 |
C14H18FNO2 |
|
2-Isopropoxy-5-methyl-4-(piperidin-4-yl)aniline dihydrochloride hydrate |
1802250-63-0 |
C15H27ClN2O2 |
|
Oseltamivir-13CD3 |
1093851-61-6 |
C16H28N2O4 |
|
3,5-Dibromo-1H-pyrazole |
67460-86-0 |
C3H2Br2N2 |
|
tert-butyl (3R,4S,5S)-4-((S)-2-amino-N,3-dimethylbutanamido)-3-methoxy-5-methylheptanoate |
177423-00-6 |
C19H38N2O4 |
|
tert-butyl 6-bromo-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-1-carboxylate |
1403901-49-4 |
C14H19BrN2O2 |
|
2H-1-Benzopyran-2-one, 6-chloro-4-methyl- |
24145-78-6 |
C10H7ClO2 |
|
7-DEAZA-2'-DEOXYINOSINE |
97224-58-3 |
C11H13N3O4 |
|
3-Iodo-1-(1-methyl-piperidin-4-ylmethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-ylamine |
1411763-96-6 |
C12H17IN6 |
|
Ethyl 6,8-dichlorooctanoate |
1070-64-0 |
C10H18Cl2O2 |
|
5-Methyl-3-phenylisoxazole-4-carbonyl chloride |
16883-16-2 |
C11H8ClNO2 |
|
2-(3,5-Dichlorophenyl)Pyrrolidine |
887344-13-0 |
C10H11Cl2N |
|
4S-fluoropyrrolidine-2R-carboxylic acid methyl ester hydrochloride salt |
131176-03-9 |
C6H11ClFNO2 |
|
3-Ethynyl-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1189793-01-8 |
C10H11N5 |
|
LOXO-292 |
2222755-14-6 |
C29H31N9O3 |
|
1-Piperazinecarboxylic acid, 2-methyl-5-[[(3R)-3-methyl-4-morpholinyl]methyl]-, 1,1-dimethylethyl ester, (2R,5S)- |
1403902-78-2 |
C16H31N3O3 |
|
2-(2-Bromophenyl)pyrrolidine |
129540-24-5 |
C10H12BrN |
|
7-Methyl-1-tetralone |
22009-37-6 |
C11H12O |
|
PROSTAGLANDIN J2 |
60203-57-8 |
C20H30O4 |
|
Prednisone Impurity 13 |
91160-89-3 |
C23H29BrO7 |
|
methyl 2-(piperidin-4-yl)-1H-benzo[d]imidazole-5-carboxylate |
|
C14H17N3O2 |
|
Thionicotinamide |
4621-66-3 |
C6H6N2S |
|
1-(tert-butyl) 4-ethyl (3R,4R)-3-hydroxypiperidine-1,4-dicarboxylate |
206111-36-6 |
C13H23NO5 |
|
(7R,13S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diyl diacetate |
1428484-17-6 |
C36H51F5O4S |
|
N'-Hydroxy-2-(pyrrolidin-1-yl)benzimidamide |
|
C11H15N3O |
|
6-Bromo-4-hydroxy-pyrazolo[1,5-a]pyridine-3-carbonitrile |
2068065-16-5 |
C8H4BrN3O |
|
2’,3’-dideoxy-2’,3’-didehydroinosine |
|
|
|
Fmoc-Ala-Ala-Asn-PABC-PNP |
1834516-06-1 |
C39H38N6O11 |
|
2’-deoxyinosine |
|
|
|
Anti-Ceftriaxong |
|
|
|
(R)-2-((trifluoromethoxy)methyl)piperazine |
|
|
|
benzyl (R)-2-(2,2-difluoroethyl)piperazine-1-carboxylate |
|
|
|
tert-butyl (S)-2-((trifluoromethoxy)methyl)piperazine-1-carboxylate |
|
|
|
tert-butyl (S)-2-(2,2,2-trifluoroethyl)piperazine-1-carboxylate |
1240582-25-5 |
C11H19F3N2O2 |
|
N6-[(5-Bromothien-2-yl)methyl]adenosine |
1706525-09-8 |
C15H16BrN5O4S |
|
4-hydroxy-6H-coumarin |
213481-01-7 |
C15H15NO3 |
|
1-Azetidinecarboxylic acid, 3-(4-iodo-1H-pyrazol-1-yl)-, 1,1-dimethylethyl ester |
951259-19-1 |
C11H16IN3O2 |
|
Cefuroxime Impurity 1(Cefuroxime Mother Nucleus) |
|
|
|
methyl 6-amino-7-fluoro-3H-benzimidazole-5-carboxylate |
918321-29-6 |
C9H8FN3O2 |
|
2-(4-METHOXY-BENZYL)-2H-PYRAZOL-3-YLAMINE |
3528-45-8 |
C11H13N3O |
|
Ozagrel sodium |
130952-46-4 |
C13H13N2NaO2 |